Marc Iskowitz MM+M - Medical Marketing and Media - Page 3 of 135

Marc Iskowitz

Most recent articles by Marc Iskowitz

Only thing more shameful than Purdue’s misleading opioid marketing: Sacklers’ refusal to accept blame
Only thing more shameful than Purdue’s misleading opioid marketing: Sacklers’ refusal to accept blame
Marc Iskowitz
December 22, 2020
5:06 pm

Family members ducked responsibility for Purdue’s marketing misdeeds, despite exerting substantial oversight over the company’s management for many years.

Purohit venture arm seeks to back biotech start-ups through ‘service as currency’ model
Purohit venture arm seeks to back biotech start-ups through ‘service as currency’ model
Marc Iskowitz
December 9, 2020
4:06 pm

The women-led investment firm fills a niche between a traditional venture fund and a commercialization agency, founder says.

The donor’s story: One marketer’s extraordinary devotion to COVID science
The donor’s story: One marketer’s extraordinary devotion to COVID science
Marc Iskowitz
December 3, 2020
5:00 am

Publicis Health Media’s Jan Weinstein is donating her plasma – and super-potent antibodies – to the development of COVID-19 therapies.

J&J makes a $100 million diversity pledge. Does it go far enough?
J&J makes a $100 million diversity pledge. Does it go far enough?
Marc Iskowitz
November 19, 2020
4:46 pm

The pledge arrived as the pandemic continued its surge, with minority communities particularly hard hit, and as cultural dialogue heated up within the industry.

GCI Health names Kristin Cahill its next global CEO
GCI Health names Kristin Cahill its next global CEO
Marc Iskowitz
November 19, 2020
9:26 am

Cahill assumes the role on January 1, as current chief exec Wendy Lund departs for a comms role at Merck spinoff Organon.

At 94.5% efficacy, Moderna’s COVID-19 vaccine appears comparable to Pfizer/BioNTech’s candidate
At 94.5% efficacy, Moderna’s COVID-19 vaccine appears comparable to Pfizer/BioNTech’s candidate
Marc Iskowitz
November 16, 2020
5:54 pm

Both vaccines have been shown to have 90%-95% efficacy. Differences in how they need to be stored could dictate how the shots are distributed.

Messaging the COVID-19 vaccine: No shot is an antidote to community concerns
Messaging the COVID-19 vaccine: No shot is an antidote to community concerns
Marc Iskowitz
November 12, 2020
8:48 am

Getting more people interested in vaccination will depend on a pivot from a biomedical mode of discussing vaccination to a more civic conversation, urges one public health expert in this Q&A.

Pfizer/BioNTech’s COVID-19 vaccine: An ‘A’ for efficacy and, potentially, for restoring hope
Pfizer/BioNTech’s COVID-19 vaccine: An ‘A’ for efficacy and, potentially, for restoring hope
Marc Iskowitz
November 9, 2020
2:01 pm

The vaccine candidate showed a 90% efficacy rate in preventing infections. The data came the same day President-Elect Biden advanced his plan to control the pandemic.

‘It’s real life.’ Pharma’s content creators adapt to coronavirus, embrace reality
‘It’s real life.’ Pharma’s content creators adapt to coronavirus, embrace reality
Marc Iskowitz
November 5, 2020
10:39 am

From COVID-safe photography to letting patients direct and produce their own videos, pharma’s commercial tactics – and their results – look a lot different nowadays.

The ‘COVID-proof’ drug launch? Why telemedicine could become a staple for more pharma brands
The ‘COVID-proof’ drug launch? Why telemedicine could become a staple for more pharma brands
Marc Iskowitz
October 29, 2020
5:00 am

Telemedicine integration — connecting patients “from ad to doctor” — is poised to become a fixture of multichannel drug marketing.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners